参考文献 1. Huber AM, Lang B, LeBlanc CM ,et al， Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum. 2000 Mar;43(3):541-9. 2. Schachna L, Ryan P F, Schwarer A P. Malignancy‐associated remission of systemic lupus erythematosus maintained by autologous peripheral blood stem cell transplantation. Arthritis Rheum 1998. 412271–2272. 3 J. A. Snowden, E. Martin-Rendon，S. M. Watt ，Clinical stem cell therapies for severe autoimmune diseases Transfusion Medicine, 2009, 19, 223–234 4. 唐湘凤,栾佐,吴凤岐,等 经CD34+纯化的自体外周造血干细胞移植治疗小儿皮肌炎1例报告 临床儿科杂志, 2007,25 (5):358-360 5.Roser Solans, Josefina Cortés, Albert Selva,et al, Panniculitis: A cutaneous manifestation of dermatomyositis J Am Acad Dermatol. 2002 May;46(5 Suppl):S148-50. 6.Snowden J A, Biggs J C, Milliken S T, et al, A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthritis Rheum 1999. 422286–2292. 7.Openshaw H, Stuve O, Antel J P,et al, Multiple sclerosis flares associated with recombinant granulocyte colony‐stimulating factor. Neurology 2000. 542147–2150. 8.Burt R K, Traynor A E, Pope R, et al Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood 1998. 923505–3514. 9. Moore J, Brooks P, Milliken S. et al A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002. 462301–2309. 10. Farge D, Passweg J, van Laar J M. et al Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis 2004. 63974–981 11.Euler HH, Marmont AM, Bacigalupo A, et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell trans- plantation. Blood 1996;88:3621–5. 12.H Tsukamoto, K Nagafuji, T Horiuchi, et al, A phase I‐II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease Ann Rheum Dis. 2006 April; 65(4): 508–514. 13. McSweeney P A, Nash R A, Sullivan K M, et al,High‐dose immunosuppressive therapy for severe systemic sclerosis: initial outcome. Blood 2002. 1001602–1610. 14.Tyndall A，Passweg J，Gratwohl A．Haemopoietic stem cell transplantation in the treatment of severe autoimmuine disease 2000 [J]． Ann Rheum Dis，2001，60(7)：702—707 15.Saccardi R, Tyndall A, Coghlan G,et al. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone marrow transplant 2004. 34877–881 16. Phillips BA, Zilko P, Garlepp MJ, Mastaglia FL Frequency of relapses in patients with polymyositis and dermatomyositis. Muscle Nerve 1998.21:1668–1672 17. Mosca M, Neri R, Pasero G,et al Treatment of idiopathic inflammatory myopathies: a retrospective analysis of 63 caucasian patients longitudinally followed at a single clinical center. Clin Exp Rheumatol 2000.18:451–456 18.Sandeep K. Agarwal . Paul A. et al.Characterization of relapses in adult idiopathic inflammatory myopathies Clin Rheumatol 2006. 25: 476–481 19. Oddis CV, Medsger TA Jr Relationship between serumcreatine kinase level and corticosteroid therapy in polymyositis–dermatomyositis. J Rheumatol 1988.15:807–811